Passive Alzheimer’s immunotherapy: A promising or uncertain option?
Poul Flemming Høilund‐Carlsen, Mona‐Elisabeth Revheim, Tommaso Costa, Abass Alavi, Kasper P. Kepp, Stefano L. Sensi, George Perry, Nikolaos K. Robakis, Jorge R. Barrio, Bryce Vissel
Topics & Concepts
MedicineClinical trialAmyloid (mycology)Food and drug administrationImmunotherapyRandomized controlled trialDiseaseOncologyInternal medicinePathologyPharmacologyCancerAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsComputational Drug Discovery Methods